Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Q93562814)
Jump to navigation
Jump to search
scholarly article published in Diabetologia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
scholarly article published in Diabetologia |
Statements
Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (English)
Y. Miao
D. Dobre
H. J. Lambers Heerspink
B. M. Brenner
M. E. Cooper
H.-H. Parving
S. Shahinfar
D. Grobbee